Acute human defibrillation performance of a subcutaneous implantable cardioverter-defibrillator with an additional coil electrode

被引:4
|
作者
Yap, Sing -Chien [7 ,8 ]
Oosterwerff, Erik F. J. [6 ]
Boersma, Lucas V. A. [1 ,2 ]
van der Stuijt, Willeke [2 ]
Lenssen, Anneke [4 ]
Hahn, Stephen J. [5 ]
Knops, Reinoud E. [3 ]
机构
[1] Erasmus MC, Cardiovasc Inst, Thorax Ctr, Dept Cardiol, Rotterdam, Netherlands
[2] Isala Klin, Dept Cardiol, Zwolle, Netherlands
[3] St Antonious Ziekenhuis, Dept Cardiol, Nieuwegein, Netherlands
[4] Univ Amsterdam, Med Ctr, Dept Cardiol, Amsterdam, Netherlands
[5] Boston Sci, Amsterdam, Netherlands
[6] Boston Sci CRM, St Paul, MN USA
[7] Flevo Hosp, Almere, Netherlands
[8] Erasmus MC, Dept Surg, Doctor Molenwaterpl 40, NL-3015 GD Rotterdam, Netherlands
关键词
Defibrillation; Subcutaneous; Human; Electrodes; Implantable cardioverter-defibrillator; OUTCOMES; TRIAL; ICD;
D O I
10.1016/j.hrthm.2023.08.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) delivers 80 J shocks from an 8 cm left-parasternal coil to a 59 cm(3) left lateral pulse generator (PG). A system that defibrillates with lower energy could significantly reduce PG size. Computer modeling and animal studies suggested that a second shock coil either parallel to the left-parasternal coil or transverse from the xiphoid to the PG pocket would significantly reduce the defibrillation threshold.Objective The purpose of this study was to acutely assess the defibrillation efficacy of parallel and transverse configurations in patients receiving an S-ICD.Methods Testing was performed in patients receiving a conventional S-ICD system. Success at 65 J was required before investigational testing. A second electrode was temporarily inserted from the xiphoid incision connected to the PG with an investigational Y-adapter. Phase 1 (n = 11) tested the parallel configuration. Phase 2 (n = 21) tested both parallel and transverse configurations in random order.Results This study enrolled 35 patients (28 males (80%); mean age 51 +/- 17 years; left ventricular ejection fraction 40% +/- 15%; body mass index 26 +/- 4 kg/m(2); prior myocardial infarction 46%; congestive heart failure 49%; cardiomyopathy 63%). Compared to the conventional S-ICD system, mean shock impedance decreased for both parallel (69 +/- 15 Omega vs 86 +/- 20 Omega; n = 33; P < .001) and transverse (56 +/- 14 Omega vs 81 +/- 21 Omega; n = 20; P < .001) configurations. Shock success rates at 20, 30, and 40 J were 55%, 79%, 97%, and 25%, 70%, 90% for parallel and transverse configurations, respectively. Defibrillation threshold testing was well tolerated with no serious adverse events.Conclusion Adding a second shock coil, particularly in the parallel configuration, significantly reduced the impedance and had a high likelihood of defibrillation success at energies <= 40 J. This may enable the development of a smaller S-ICD.
引用
收藏
页码:1649 / 1656
页数:8
相关论文
共 50 条
  • [41] Pocket infection as a complication of a subcutaneous implantable cardioverter-defibrillator
    Calvagna, Giuseppe Mario
    Ceresa, Fabrizio
    Patane, Salvatore
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (02) : 616 - 618
  • [42] Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias
    Raja, Joel
    Guice, Kenneth
    Oberoi, Mansi
    Whitwell, Samantha
    Asbeutah, Abdul Aziz
    Russell, Alex
    Khouzam, Rami N.
    CURRENT PROBLEMS IN CARDIOLOGY, 2022, 47 (09)
  • [43] The subcutaneous implantable cardioverter-defibrillator: A tertiary center experience
    Khazen, Cesar
    Magnusson, Peter
    Flandorfer, Johannes
    Schukro, Christoph
    CARDIOLOGY JOURNAL, 2019, 26 (05) : 543 - 549
  • [44] The implantable cardioverter-defibrillator
    Raj, SR
    Sheldon, RS
    PROGRESS IN CARDIOVASCULAR DISEASES, 2001, 44 (03) : 169 - 194
  • [45] The implantable cardioverter-defibrillator
    Greene, HL
    CLINICAL CARDIOLOGY, 2000, 23 (05) : 315 - 326
  • [46] The implantable cardioverter-defibrillator
    Groh, WJ
    Foreman, LD
    Zipes, DP
    AMERICAN FAMILY PHYSICIAN, 1998, 57 (02) : 310 - 312
  • [47] The Subcutaneous Implantable Defibrillator: A New Technology That Raises an Existential Question for the Implantable Cardioverter-Defibrillator
    Saxon, Leslie A.
    CIRCULATION, 2013, 128 (09) : 938 - 940
  • [48] Acute shock efficacy of the subcutaneous implantable cardioverter-defibrillator according to the implantation technique
    Francia, Pietro
    Adduci, Carmen
    Angeletti, Andrea
    Ottaviano, Luca
    Perrotta, Laura
    De Vivo, Stefano
    Bongiorni, Maria Grazia
    Migliore, Federico
    Dello Russo, Antonio
    De Filippo, Paolo
    Caravati, Fabrizio
    Nigro, Gerardo
    Palmisano, Pietro
    Viani, Stefano
    D'Onofrio, Antonio
    Lovecchio, Mariolina
    Valsecchi, Sergio
    Ziacchi, Matteo
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2021, 32 (06) : 1695 - 1703
  • [49] Subcutaneous implantable cardioverter-defibrillator electrode fracture: Follow-up, troubleshooting, and evaluation
    Kella, Danesh K.
    Stambler, Bruce S.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2021, 32 (05) : 1452 - 1457
  • [50] Substernal and subcutaneous electrocardiograms during subcutaneous implantable cardioverter-defibrillator implantation
    Ishida, Yuji
    Itoh, Taihei
    Sasaki, Shingo
    Washima, Shota
    Toyama, Yuichi
    Tomita, Hirofumi
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2022, 64 (01) : 235 - 236